Market Place
Sourcing Support
SINOVAC Announces Nasdaq Hearings Panel Grants Continued Listing
22 Jan 2026 //
BUSINESSWIRE
SINOVAC Updates Antigua High Court Order And Auditor Engagement
04 Jan 2026 //
BUSINESSWIRE
Sinovac Board Secures Interim Control Amid Shareholder Meeting
17 Dec 2025 //
BUSINESSWIRE
Sinovac Receives Nasdaq Delisting Notice, Plans Appeal
18 Nov 2025 //
BUSINESSWIRE
Sinovac Shareholders Back Urgent Dividend Payout
12 Nov 2025 //
PR NEWSWIRE
SINOVAC Announces Appointment Of Independent Auditor
24 Oct 2025 //
BUSINESSWIRE
SINOVAC Board Clarifies July 8 Shareholders` Special Meeting
11 Jul 2025 //
BUSINESSWIRE
Newly Elected Directors of Sinovac Hold the First Board Meeting
10 Jul 2025 //
BUSINESSWIRE
SINOVAC Adjourns Shareholders Meeting Pending Court Decision
09 Jul 2025 //
BUSINESSWIRE
Final Call: SINOVAC Shareholders to Vote Against Proposals 1 & 2
07 Jul 2025 //
BUSINESSWIRE
ISS, Glass Lewis Join Back Current SINOVAC Board in Vote
03 Jul 2025 //
BUSINESSWIRE
Glass Lewis Recommends SINOVAC Shareholders Keep Current Board
02 Jul 2025 //
BUSINESSWIRE
Court Bars 1Globe, Jiaqiang Li From Misleading Sinovac Claims
02 Jul 2025 //
BUSINESSWIRE
Sinovac Urges Shareholders to Reject Board Removal Plan
30 Jun 2025 //
BUSINESSWIRE
SINOVAC Board Issues Investor Presentation to Defend Control
24 Jun 2025 //
BUSINESSWIRE
Prime Success Welcomes NY Ruling on Sinovac Shareholder Vote
21 Jun 2025 //
BUSINESSWIRE
Sinovac Board Wins Against Advantech/Prime in New York Lawsuit
20 Jun 2025 //
BUSINESSWIRE
SINOVAC Board of Directors Files Definitive Proxy Materials
18 Jun 2025 //
BUSINESSWIRE
Sinovac Sets Record and Distribution Dates for Cash Dividend
30 Apr 2025 //
BUSINESSWIRE
Sinovac Board Letter Sets Record Straight on Vivo Capital
29 Apr 2025 //
BUSINESSWIRE
SINOVAC Announces Decision to Declare Cash Dividend
31 Mar 2025 //
BUSINESSWIRE
SINOVAC appoints new board member and audit committee chairman
28 Mar 2025 //
BUSINESSWIRE
SINOVAC Announces New Board Following Privy Council Judgment
28 Feb 2025 //
BUSINESSWIRE
SINOVAC Issues Statement Regarding Privy Council Judgment
16 Jan 2025 //
BUSINESSWIRE
SINOVAC Initiates Phase III Trial for Bivalent HFMD Vaccine
16 Dec 2024 //
BUSINESSWIRE
SINOVAC Reports Unaudited First Half of 2024 Financial Results
16 Aug 2024 //
BUSINESSWIRE
SINOVAC Reports on Trial Progress of Anti-COVID-19 Antibody SA55 Injection
11 Sep 2023 //
BUSINESSWIRE
Sinovac Biotech gets approval for clinical trial of Covid-19 injection
30 May 2023 //
CLINICAL TRIALS ARENA
